Profile
Sector:
HealthcareIndustry:
Medical Instruments & SuppliesCountry:
United StatesIPO:
17 May 2019Website:
http://www.avantorsciences.comNext earnings report:
14 February 2025Last dividends:
N/ANext dividends:
N/APrice
after hours | 32 min agoDividend
Analysts recommendations
Institutional Ownership
AVTR Latest News
RADNOR, Pa. , Nov. 20, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that President and CEO, Michael Stubblefield, will be participating in a fireside chat at the Evercore ISI HealthCONx Conference in Coral Gables, Florida on Tuesday, December 3, at 9:10 a.m.
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, has announced a distribution agreement with Avantor® (NYSE: AVTR), a global leader in mission-critical products and services for the life sciences and advanced technology industries. Through this collaboration, Avantor will distribute Quantum-Si's Next-Generation Protein Sequencing (NGPS) portfolio, providing researchers across all market segments in t.
Investors looking for stocks in the Medical Services sector might want to consider either Pediatrix Medical Group (MD) or Avantor, Inc. (AVTR). But which of these two companies is the best option for those looking for undervalued stocks?
Despite AVTR's continued stability in the Education and Advanced Technology end markets, it reports an overall soft third-quarter performance.
Avantor Inc. (NYSE:AVTR ) Q3 2024 Earnings Conference Call October 25, 2024 8:00 AM ET Company Participants Christina Jones - VP, IR Michael Stubblefield - President and Chief Executive Officer Brent Jones - Executive Vice President and Chief Financial Officer Conference Call Participants Daniel Brennan - TD Cowen Douglas Schenkel - Wolfe Research Tycho Peterson - Jefferies Michael Ryskin - Bank of America Vijay Kumar - Evercore ISI Daniel Leonard - UBS Conor McNamara - RBC Capital Markets Daniel Arias - Stifel Rachel Vatnsdal - JP Morgan Luke Sergott - Barclays Tejas Savant - Morgan Stanley Operator Good morning. My name is Emily, and I will be your conference operator today.
The headline numbers for Avantor (AVTR) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Avantor, Inc. (AVTR) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.25 per share a year ago.
Net sales of $1.71 billion, decrease of 0.3%; organic decline of 0.7% Net income of $57.8 million; Adjusted EBITDA of $302.5 million Diluted GAAP EPS of $0.08; adjusted EPS of $0.26 Operating cash flow of $244.8 million; free cash flow of $204.0 million RADNOR, Pa. , Oct. 25, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its third fiscal quarter ended September 30, 2024.
Avantor and NIBRT have formed a new partnership to supply advanced Masterflex® equipment, essential products, and expert training to foster innovations in biopharma manufacturing RADNOR, Pa. , Oct. 23, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced an expanded partnership with the National Institute for Bioprocessing Research and Training (NIBRT).
Avantor closes its deal with Audax to divest its clinical services business.
What type of business is Avantor?
Avantor, Inc. is an American company specializing in the production of materials and equipment for the biopharmaceutical and healthcare industries. It has a history dating back to 1904 and was officially registered in its current form in 2017 in the state of Delaware. The portfolio of products and services includes: - Materials and consumables, including chemicals and reagents, laboratory products and consumables, specialized silicone materials, customized excipients, individual disposable assemblies, and more. - Equipment and instruments, such as filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low temperature freezers, biological safety cabinets, and materials for critical environments. - Services and specialized procurement, including laboratory and manufacturing services, procurement services, as well as services for the development of biopharmaceutical materials.
What sector is Avantor in?
Avantor is in the Healthcare sector
What industry is Avantor in?
Avantor is in the Medical Instruments & Supplies industry
What country is Avantor from?
Avantor is headquartered in United States
When did Avantor go public?
Avantor initial public offering (IPO) was on 17 May 2019
What is Avantor website?
https://www.avantorsciences.com
Is Avantor in the S&P 500?
No, Avantor is not included in the S&P 500 index
Is Avantor in the NASDAQ 100?
No, Avantor is not included in the NASDAQ 100 index
Is Avantor in the Dow Jones?
No, Avantor is not included in the Dow Jones index
When was Avantor the previous earnings report?
No data
When does Avantor earnings report?
The next expected earnings date for Avantor is 14 February 2025